These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34551289)

  • 1. PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation.
    Gu X; Enane F; Tohme R; Schuerger C; Radivoyevitch T; Parker Y; Zuberi E; Przychodzen B; Jha BK; Lindner D; Rini B; Saunthararajah Y
    Cell Rep; 2021 Sep; 36(12):109747. PubMed ID: 34551289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBRM1 bromodomains variably influence nucleosome interactions and cellular function.
    Slaughter MJ; Shanle EK; McFadden AW; Hollis ES; Suttle LE; Strahl BD; Davis IJ
    J Biol Chem; 2018 Aug; 293(35):13592-13603. PubMed ID: 29986887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual Bromodomains of Polybromo-1 Contribute to Chromatin Association and Tumor Suppression in Clear Cell Renal Carcinoma.
    Porter EG; Dykhuizen EC
    J Biol Chem; 2017 Feb; 292(7):2601-2610. PubMed ID: 28053089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.
    Gao W; Li W; Xiao T; Liu XS; Kaelin WG
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1027-1032. PubMed ID: 28082722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.
    Chowdhury B; Porter EG; Stewart JC; Ferreira CR; Schipma MJ; Dykhuizen EC
    PLoS One; 2016; 11(4):e0153718. PubMed ID: 27100670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas.
    Macher-Goeppinger S; Keith M; Tagscherer KE; Singer S; Winkler J; Hofmann TG; Pahernik S; Duensing S; Hohenfellner M; Kopitz J; Schirmacher P; Roth W
    J Pathol; 2015 Dec; 237(4):460-71. PubMed ID: 26178300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.
    Yao X; Hong JH; Nargund AM; Ng MSW; Heng HL; Li Z; Guan P; Sugiura M; Chu PL; Wang LC; Ye X; Qu J; Kwek XY; Lim JCT; Ooi WF; Koh J; Wang Z; Pan YF; Ong YS; Tan KY; Goh JY; Ng SR; Pignata L; Huang D; Lezhava A; Tay ST; Lee M; Yeo XH; Tam WL; Rha SY; Li S; Guccione E; Futreal A; Tan J; Yeong JPS; Hong W; Yauch R; Chang KT; Sobota RM; Tan P; Teh BT
    Nat Cell Biol; 2023 May; 25(5):765-777. PubMed ID: 37095322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.
    Schoenfeld DA; Zhou R; Zairis S; Su W; Steinbach N; Mathur D; Bansal A; Zachem AL; Tavarez B; Hasson D; Bernstein E; Rabadan R; Parsons R
    Mol Cancer Res; 2022 Aug; 20(8):1193-1207. PubMed ID: 35412614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma.
    Bleu M; Gaulis S; Lopes R; Sprouffske K; Apfel V; Holwerda S; Pregnolato M; Yildiz U; Cordoʹ V; Dost AFM; Knehr J; Carbone W; Lohmann F; Lin CY; Bradner JE; Kauffmann A; Tordella L; Roma G; Galli GG
    Nat Commun; 2019 Aug; 10(1):3739. PubMed ID: 31431624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
    Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
    Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.
    Nargund AM; Pham CG; Dong Y; Wang PI; Osmangeyoglu HU; Xie Y; Aras O; Han S; Oyama T; Takeda S; Ray CE; Dong Z; Berge M; Hakimi AA; Monette S; Lekaye CL; Koutcher JA; Leslie CS; Creighton CJ; Weinhold N; Lee W; Tickoo SK; Wang Z; Cheng EH; Hsieh JJ
    Cell Rep; 2017 Mar; 18(12):2893-2906. PubMed ID: 28329682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of PBRM1 expression is associated with renal cell carcinoma progression.
    Pawłowski R; Mühl SM; Sulser T; Krek W; Moch H; Schraml P
    Int J Cancer; 2013 Jan; 132(2):E11-7. PubMed ID: 22949125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kid-1 expression is high in differentiated renal proximal tubule cells and suppressed in cyst epithelia.
    Witzgall R; Obermüller N; Bölitz U; Calvet JP; Cowley BD; Walker C; Kriz W; Gretz N; Bonventre JV
    Am J Physiol; 1998 Dec; 275(6):F928-37. PubMed ID: 9843910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBRM1 bromodomains associate with RNA to facilitate chromatin association.
    De Silva SM; Dhiman A; Sood S; Mercedes KF; Simmons WJ; Henen MA; Vögeli B; Dykhuizen EC; Musselman CA
    Nucleic Acids Res; 2023 May; 51(8):3631-3649. PubMed ID: 36808431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.
    Enane FO; Saunthararajah Y; Korc M
    Cell Death Dis; 2018 Sep; 9(9):912. PubMed ID: 30190481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end-stage renal disease.
    Ishihara H; Yamashita S; Liu YY; Hattori N; El-Omar O; Ikeda T; Fukuda H; Yoshida K; Takagi T; Taneda S; Kondo T; Nagashima Y; Tanabe K; Ushijima T
    Cancer Sci; 2020 Nov; 111(11):4276-4287. PubMed ID: 32860304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.
    Wang H; Qu Y; Dai B; Zhu Y; Shi G; Zhu Y; Shen Y; Zhang H; Ye D
    PLoS One; 2017; 12(8):e0180862. PubMed ID: 28846693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
    Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
    J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.